» Articles » PMID: 15542680

Differential Requirement for Cell Fusion and Virion Formation in the Pathogenesis of Varicella-zoster Virus Infection in Skin and T Cells

Overview
Journal J Virol
Date 2004 Nov 16
PMID 15542680
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

The protein product of varicella-zoster virus (VZV) ORF47 is a serine/threonine protein kinase and tegument component. Evaluation of two recombinants of the Oka strain, rOka47DeltaC, with a C-terminal truncation of ORF47, and rOka47D-N, with a point mutation in the conserved kinase motif, showed that ORF47 kinase function was necessary for optimal VZV replication in human skin xenografts in SCID mice but not in cultured cells. We now demonstrate that rOka47DeltaC and rOka47D-N mutants do not infect human T-cell xenografts. Differences in the growth of kinase-defective ORF47 mutants allowed an examination of requirements for VZV pathogenesis in skin and T cells in vivo. Although virion assembly was reduced and no virion transport to cell surfaces was observed, epidermal cell fusion persisted, and VZV polykaryocytes were generated by rOka47DeltaC and rOka47D-N in skin. Virion assembly was also impaired in vitro, but VZV-induced cell fusion continued to cause syncytia in cultured cells infected with rOka47DeltaC or rOka47D-N. Intracellular trafficking of envelope glycoprotein E and the ORF47 and IE62 proteins, components of the tegument, was aberrant without ORF47 kinase activity. In summary, normal VZV virion assembly appears to require ORF47 kinase function. Cell fusion was induced by ORF47 mutants in skin, and cell-cell spread occurred even though virion formation was deficient. VZV-infected T cells do not undergo cell fusion, and impaired virion assembly by ORF47 mutants was associated with a complete elimination of T-cell infectivity. These observations suggest a differential requirement for cell fusion and virion formation in the pathogenesis of VZV infection in skin and T cells.

Citing Articles

Creating the "Dew Drop on a Rose Petal": the Molecular Pathogenesis of Varicella-Zoster Virus Skin Lesions.

Arvin A Microbiol Mol Biol Rev. 2023; 87(3):e0011622.

PMID: 37354037 PMC: 10521358. DOI: 10.1128/mmbr.00116-22.


The Biology of Varicella-Zoster Virus Replication in the Skin.

Tommasi C, Breuer J Viruses. 2022; 14(5).

PMID: 35632723 PMC: 9147561. DOI: 10.3390/v14050982.


Insights into the pathogenesis of varicella viruses.

Sorel O, Messaoudi I Curr Clin Microbiol Rep. 2020; 6(3):156-165.

PMID: 32999816 PMC: 7523919. DOI: 10.1007/s40588-019-00119-2.


Dysregulated Glycoprotein B-Mediated Cell-Cell Fusion Disrupts Varicella-Zoster Virus and Host Gene Transcription during Infection.

Oliver S, Yang E, Arvin A J Virol. 2016; 91(1).

PMID: 27795423 PMC: 5165202. DOI: 10.1128/JVI.01613-16.


Molecular mechanisms of varicella zoster virus pathogenesis.

Zerboni L, Sen N, Oliver S, Arvin A Nat Rev Microbiol. 2014; 12(3):197-210.

PMID: 24509782 PMC: 4066823. DOI: 10.1038/nrmicro3215.


References
1.
Niizuma T, Zerboni L, Sommer M, Ito H, Hinchliffe S, Arvin A . Construction of varicella-zoster virus recombinants from parent Oka cosmids and demonstration that ORF65 protein is dispensable for infection of human skin and T cells in the SCID-hu mouse model. J Virol. 2003; 77(10):6062-5. PMC: 154042. DOI: 10.1128/jvi.77.10.6062-6065.2003. View

2.
Moffat J, Zerboni L, Sommer M, Heineman T, Cohen J, KANESHIMA H . The ORF47 and ORF66 putative protein kinases of varicella-zoster virus determine tropism for human T cells and skin in the SCID-hu mouse. Proc Natl Acad Sci U S A. 1998; 95(20):11969-74. PMC: 21749. DOI: 10.1073/pnas.95.20.11969. View

3.
Santos R, HATFIELD C, Cole N, Padilla J, Moffat J, Arvin A . Varicella-zoster virus gE escape mutant VZV-MSP exhibits an accelerated cell-to-cell spread phenotype in both infected cell cultures and SCID-hu mice. Virology. 2000; 275(2):306-17. DOI: 10.1006/viro.2000.0507. View

4.
Kemble G, Annunziato P, Lungu O, Winter R, Cha T, Silverstein S . Open reading frame S/L of varicella-zoster virus encodes a cytoplasmic protein expressed in infected cells. J Virol. 2000; 74(23):11311-21. PMC: 113236. DOI: 10.1128/jvi.74.23.11311-11321.2000. View

5.
Wang Z, Gershon M, Lungu O, Zhu Z, Mallory S, Arvin A . Essential role played by the C-terminal domain of glycoprotein I in envelopment of varicella-zoster virus in the trans-Golgi network: interactions of glycoproteins with tegument. J Virol. 2000; 75(1):323-40. PMC: 113926. DOI: 10.1128/JVI.75.1.323-340.2001. View